These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8475481)
1. Effects of Policosanol on platelet aggregation in rats. Arruzazabala ML; Carbajal D; Mas R; Garcia M; Fraga V Thromb Res; 1993 Feb; 69(3):321-7. PubMed ID: 8475481 [TBL] [Abstract][Full Text] [Related]
2. Modulation of platelet functions by crude rice (Oryza sativa) bran policosanol extract. Wong WT; Ismail M; Imam MU; Zhang YD BMC Complement Altern Med; 2016 Jul; 16():252. PubMed ID: 27465266 [TBL] [Abstract][Full Text] [Related]
3. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers. Carbajal D; Arruzazabala ML; Valdés S; Más R Prostaglandins Leukot Essent Fatty Acids; 1998 Jan; 58(1):61-4. PubMed ID: 9482167 [TBL] [Abstract][Full Text] [Related]
4. Effect of policosanol on platelet aggregation in healthy volunteers. Valdes S; Arruzazabala ML; Fernandez L; Más R; Carbajal D; Aleman C; Molina V Int J Clin Pharmacol Res; 1996; 16(2-3):67-72. PubMed ID: 9063758 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients. Arruzazabala ML; Molina V; Mas R; Fernández L; Carbajal D; Valdés S; Castaño G Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):891-7. PubMed ID: 12207568 [TBL] [Abstract][Full Text] [Related]
6. Effect of policosanol successive dose increases on platelet aggregation in healthy volunteers. Arruzazabala ML; Valdés S; Más R; Fernández L; Carbajal D Pharmacol Res; 1996; 34(5-6):181-5. PubMed ID: 9076841 [TBL] [Abstract][Full Text] [Related]
7. Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits. Gámez R; Máz R; Arruzazabala ML; Mendoza S; Castaño G Drugs R D; 2005; 6(1):11-9. PubMed ID: 15806713 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis. Xuan B; Wang W; Li DX Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):133-5. PubMed ID: 8010106 [TBL] [Abstract][Full Text] [Related]
9. Effect of policosanol on platelet aggregation in type II hypercholesterolemic patients. Arruzazabala ML; Más R; Molina V; Carbajal D; Mendoza S; Fernández L; Valdés S Int J Tissue React; 1998; 20(4):119-24. PubMed ID: 10093795 [TBL] [Abstract][Full Text] [Related]
10. Effect of policosanol on cerebral ischemia in Mongolian gerbils: role of prostacyclin and thromboxane A2. Arruzazabala ML; Molina V; Carbajal D; Valdés S; Más R Prostaglandins Leukot Essent Fatty Acids; 1993 Sep; 49(3):695-7. PubMed ID: 8248276 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of policosanol, aspirin and the combination therapy policosanol-aspirin on platelet aggregation in healthy volunteers. Arruzazabala ML; Valdés S; Más R; Carbajal D; Fernández L Pharmacol Res; 1997 Oct; 36(4):293-7. PubMed ID: 9425618 [TBL] [Abstract][Full Text] [Related]
12. [Effects of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion]. Wu JF; Liu TP Yao Xue Xue Bao; 1995; 30(2):98-102. PubMed ID: 7785438 [TBL] [Abstract][Full Text] [Related]
13. Antihistaminic drug bromadryl and stimulated platelet aggregation. Nosál R; Jancinová V; Petríková M Agents Actions; 1994 Jun; 41 Spec No():C104-5. PubMed ID: 7976789 [TBL] [Abstract][Full Text] [Related]
14. Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats. Akagi Y; Nio Y; Shimada S; Aoyama T Biol Pharm Bull; 2011; 34(2):233-7. PubMed ID: 21415533 [TBL] [Abstract][Full Text] [Related]
15. In-vitro and ex-vivo inhibition of blood platelet aggregation by naftazone. Durand P; Bloy C; Peltier-Pujol F; Blache D J Pharm Pharmacol; 1996 Jun; 48(6):566-72. PubMed ID: 8832488 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet aggregation in whole blood by alcohol. Torres Duarte AP; Dong QS; Young J; Abi-Younes S; Myers AK Thromb Res; 1995 Apr; 78(2):107-15. PubMed ID: 7482428 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of G619, a new platelet aggregation inhibitor. Yue TL; Smith EF; Ohlstein EH; Sulpizio A; Slivjak MJ; Rabinovici R; Sellers TS; Lynch KM; Poyser R; Feuerstein G Thromb Res; 1992 May; 66(4):331-47. PubMed ID: 1412200 [TBL] [Abstract][Full Text] [Related]
18. Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates. Terres W; Umnus S; Mathey DG; Bleifeld W Cardiovasc Res; 1990 Jun; 24(6):471-7. PubMed ID: 2167173 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet effect of gingerol isolated from Zingiber officinale. Guh JH; Ko FN; Jong TT; Teng CM J Pharm Pharmacol; 1995 Apr; 47(4):329-32. PubMed ID: 7791032 [TBL] [Abstract][Full Text] [Related]
20. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]